Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Gremlin - a putative pathogenic player in progressive renal disease.

Vincent Dolan¹, Madeline Murphy, Pilar Alarcon

¹Centre for Integrative Biology, Conway Institute of Biomolecular and Biomedical Research, Department of Medicine and Therapeutics, University College Dublin, The Dulin Molecular Medicine Centre, Belfield, Ireland. vincent.dolan@ucd.ie

Expert Opinion on Therapeutic Targets

|July 30, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cefiderocol-containing regimens versus best available therapy for carbapenem-resistant Acinetobacter infections.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2025

Same author

Research Review: Pharmacological and non-pharmacological treatments for adolescents with attention deficit/hyperactivity disorder - a systematic review of the literature.

Journal of child psychology and psychiatry, and allied disciplines·2024

Same author

Bone morphogenetic protein-3 is a negative regulator of transforming growth factor beta and fibrosis.

Biochemical and biophysical research communications·2024

Same author

Did our cochlear implant program make any difference in the lives of our patients? Achievements of 30 patients with long term follow-up averaging 20 years after cochlear implantation.

Acta oto-laryngologica·2023

Same author

Bone marrow transplantation as a therapy for autosomal dominant osteopetrosis type 2 in mice.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2022

Same author

Post-intubation subglottic stenosis: aetiology at the cellular and molecular level.

European respiratory review : an official journal of the European Respiratory Society·2021

Progressive renal fibrosis leads to kidney failure, and current treatments are insufficient. Gremlin, a bone morphogenetic protein regulator, shows promise as a novel therapeutic target for halting kidney disease progression.

Area of Science:

Nephrology
Molecular Biology
Developmental Biology

Background:

Progressive renal fibrosis is a major cause of end-stage renal disease.
Existing therapies for chronic renal failure only slow disease progression, failing to halt it.
Understanding the mechanisms of glomerulosclerosis and tubulointerstitial fibrosis is crucial for developing new treatments.

Purpose of the Study:

To investigate the role of gremlin in progressive renal diseases.
To explore gremlin as a potential therapeutic target for kidney fibrosis.

Main Methods:

The study implicates gremlin, a regulator of bone morphogenetic proteins (BMPs).
Gremlin's involvement in glomerulosclerosis, tubulointerstitial fibrosis, and cellular hypertrophy was examined.

Related Experiment Videos

Main Results:

Gremlin has been implicated in key fibrotic processes in the kidney.
The findings suggest gremlin's significant role in the pathogenesis of progressive renal diseases.

Conclusions:

Gremlin emerges as a potential novel therapeutic target for progressive renal diseases.
Targeting gremlin may offer a new strategy to halt or reverse kidney fibrosis and failure.